Western Blot (WB)
(Figure 1 Western Blot Validation of PUMA in K562 and 3T3/NIH CellsLoading: 15 μg of lysates per lane.Antibodies: 3041 (2 μg/mL), 1 h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.)
Rabbit anti-Human, Mouse PUMA Polyclonal Antibody | anti-BBC3 antibody
PUMA Antibody
Western Blot (WB)
(Figure 1 Western Blot Validation of PUMA in K562 and 3T3/NIH CellsLoading: 15 μg of lysates per lane.Antibodies: 3041 (2 μg/mL), 1 h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.)
Western Blot (WB)
(Figure 1 Western Blot Validation of PUMA in K562 and 3T3/NIH CellsLoading: 15 μg of lysates per lane.Antibodies: 3041 (2 μg/mL), 1 h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.)
Western Blot (WB)
(Figure 2 Independent Antibody Validation (IAV) via Protein Expression ProfileLoading: 20 μg of lysates per lane.Antibodies: 3041 (3 μg/mL), 3043 (2 μg/mL), beta-actin (1 μg/mL) and GAPDH (0.02 μg/mL), 1 h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.)
Western Blot (WB)
(Figure 2 Independent Antibody Validation (IAV) via Protein Expression ProfileLoading: 20 μg of lysates per lane.Antibodies: 3041 (3 μg/mL), 3043 (2 μg/mL), beta-actin (1 μg/mL) and GAPDH (0.02 μg/mL), 1 h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.)
Western Blot (WB)
(Figure 3 Validation with PUMA siRNA Knockdown293 cells were transfected with control siRNAs (lane 1) or PUMA siRNAs (lane 2)Loading: 15 μg of 293 whole cell lysates per lane.Antibodies: 3041 (2 μg/mL), beta-actin (1 μg/mL) and GAPDH (0.02 μg/mL), 1 h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.)
Western Blot (WB)
(Figure 3 Validation with PUMA siRNA Knockdown293 cells were transfected with control siRNAs (lane 1) or PUMA siRNAs (lane 2)Loading: 15 μg of 293 whole cell lysates per lane.Antibodies: 3041 (2 μg/mL), beta-actin (1 μg/mL) and GAPDH (0.02 μg/mL), 1 h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.)
Western Blot (WB)
(Figure 4 Sensitivity Test for PUMALoading: Lysates/proteins at 15 μg per lane.Antibodies: 3041 (lane 1-3: 1, 2 and 4 μg/mL). 1 h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.)
Western Blot (WB)
(Figure 4 Sensitivity Test for PUMALoading: Lysates/proteins at 15 μg per lane.Antibodies: 3041 (lane 1-3: 1, 2 and 4 μg/mL). 1 h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.)
Immunofluorescence (IF)
(Figure 5 Immunofluorescence Validation of PUMAImmunofluorescent analysis of 4% paraformaldehyde-fixed K562 cells labeling PUMA with 3041 at 2 μg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red). Image showing cytosol staining on K562 cells.)
Immunofluorescence (IF)
(Figure 5 Immunofluorescence Validation of PUMAImmunofluorescent analysis of 4% paraformaldehyde-fixed K562 cells labeling PUMA with 3041 at 2 μg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red). Image showing cytosol staining on K562 cells.)
Immunocytochemistry (ICC)
(Figure 6 Immunocytochemistry Validation of PUMAImmunocytochemical analysis of 4% paraformaldehyde-fixed K562 cells labeling PUMA with 3041 at 1 μg/ml, followed by goat anti-rabbit IgG secondary antibody at 1/250 dilution. Image showing both cytosol staining on K562 cells.)
Immunocytochemistry (ICC)
(Figure 6 Immunocytochemistry Validation of PUMAImmunocytochemical analysis of 4% paraformaldehyde-fixed K562 cells labeling PUMA with 3041 at 1 μg/ml, followed by goat anti-rabbit IgG secondary antibody at 1/250 dilution. Image showing both cytosol staining on K562 cells.)
Western Blot (WB)
(Figure 7 KD Validation of PUMA (Elgendy et al., 2011)HOSE-RasV12 cells were transfected with control shRNA plasmid or shRNA plasmids (KD) targeted against Noxa or Puma, as indicated. PUMA expression was not observed in PUMA KD cells detected by anti-PUMA antibodies (3041).)
Western Blot (WB)
(Figure 7 KD Validation of PUMA (Elgendy et al., 2011)HOSE-RasV12 cells were transfected with control shRNA plasmid or shRNA plasmids (KD) targeted against Noxa or Puma, as indicated. PUMA expression was not observed in PUMA KD cells detected by anti-PUMA antibodies (3041).)
Western Blot (WB)
(Figure 8 Induction Validation of PUMA (Sabirzhanov et al., 2014)PUMA protein levels were increased in etoposide-treated primary cortical neurons detected by anti-PUMA antibodies (3041).)
Western Blot (WB)
(Figure 8 Induction Validation of PUMA (Sabirzhanov et al., 2014)PUMA protein levels were increased in etoposide-treated primary cortical neurons detected by anti-PUMA antibodies (3041).)
Western Blot (WB)
(Figure 9 KD Validation of PUMA (Han et al., 2010)Immunoblot analyses of Tet-induced p53 cells treated with NOXA, Puma, Bim or non-targeting siRNAs that were utilized in this experiment. PUMA protein levels were markedly reduced in PUMA KD cells detected by anti-PUMA antibodies (3041).)
Western Blot (WB)
(Figure 9 KD Validation of PUMA (Han et al., 2010)Immunoblot analyses of Tet-induced p53 cells treated with NOXA, Puma, Bim or non-targeting siRNAs that were utilized in this experiment. PUMA protein levels were markedly reduced in PUMA KD cells detected by anti-PUMA antibodies (3041).)
NCBI and Uniprot Product Information
NCBI Description
This gene encodes a member of the BCL-2 family of proteins. This family member belongs to the BH3-only pro-apoptotic subclass. The protein cooperates with direct activator proteins to induce mitochondrial outer membrane permeabilization and apoptosis. It can bind to anti-apoptotic Bcl-2 family members to induce mitochondrial dysfunction and caspase activation. Because of its pro-apoptotic role, this gene is a potential drug target for cancer therapy and for tissue injury. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011]
Uniprot Description
BBC3B: Essential mediator of p53/TP53-dependent and p53/TP53- independent apoptosis. Isoform 3 fails to show any growth- inhibitory or apoptotic activity. Induced by DNA damage, glucocorticoid treatment, growth factor deprivation and p53/TP53. {ECO:0000269|PubMed:11463392}. Isoform 3 does not interact with BCL2. 4 isoforms of the human protein are produced by alternative splicing
Protein type: Mitochondrial; Apoptosis
Chromosomal Location of Human Ortholog: 19q13.3-q13.4
Cellular Component: mitochondrial outer membrane; mitochondrion; cytosol
Molecular Function: protein binding
Biological Process: caspase activation; release of cytochrome c from mitochondria; positive regulation of protein homooligomerization; apoptosis; reduction of endoplasmic reticulum calcium ion concentration; positive regulation of neuron apoptosis; release of sequestered calcium ion into cytosol; determination of adult life span; response to DNA damage stimulus; negative regulation of growth
Research Articles on BBC3
Similar Products
Product Notes
The BBC3 bbc3 (Catalog #AAA151208) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The PUMA Antibody reacts with Human, Mouse and may cross-react with other species as described in the data sheet. AAA Biotech's PUMA can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB), Immunocytochemistry (ICC), Immunofluorescence (IF). PUMA antibody can be used for detection of PUMA by Western blot at 2 mug/mL. Antibody can also be used for immunocytochemstry at 1 mug/mL. For immunofluorescence start at 2 mug/mL. Knockdown (Knockout, KO validated) Antibody. Researchers should empirically determine the suitability of the BBC3 bbc3 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "PUMA, Polyclonal Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.
